Prior Auth Required
61958 - NDC: -2901-1
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / ServiceNDC: -2901-1
Procedure / Service Description
Use Authorization Inpatient treatment of COVID-19 infection in adults and children requiring hospitalization (see below). - for progressing to severe COVID-19 including hospitalization and/or death (see below). Availability 100 mg of remdesivir for injection as a lyophilized powder, in a single-dose vial NDC: 61958-2901-1 100 mg/20 mL (5 mg/mL) remdesivir injection, in a single-dose vial
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.